Recruiting Primary Biliary Cholangitis Studies in Boston
About Primary Biliary Cholangitis Clinical Trials in Boston
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease in which the bile ducts in the liver are slowly destroyed. This leads to bile buildup, liver damage, and potentially cirrhosis. Treatment includes ursodeoxycholic acid and obeticholic acid.
There are currently 1 primary biliary cholangitis clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 424 participants. Research is being sponsored by Ipsen. Clinical trial participation is free and participants receive study-related medical care at no cost.
Primary Biliary Cholangitis Clinical Trials in Boston — FAQ
Are there primary biliary cholangitis clinical trials in Boston?
Yes, there are 1 primary biliary cholangitis clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.
Are clinical trials in Boston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.
What primary biliary cholangitis treatments are being tested?
The 1 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for primary biliary cholangitis.
Data updated July 13, 2026 from ClinicalTrials.gov